LuSeed Vascular is a pioneering medical technology startup that focuses on advancing neurovascular innovation.

LuSeed’s ARC is a first-in-class, minimally invasive device for treating both Bifurcation and Sidewall brain aneurysms simply and safely. The device is designed for full compatibility with robotic systems.
Its mission is to provide a standard method of care, easily implemented by neuro radiologists at various experience levels, to improve both acute and long-term patient outcomes, mitigate potential complications, and optimize hospitals’ operational and financial burdens.

LuSeed has currently began its clinical phase, with so far highly promising results.